print PRINT

SCIENCE > Health

Gilead to provide remdesivir to Japan free of charge

  • May 8, 2020
  • , Kyodo
  • JMH Summary

Kyodo News reported that the Japanese unit of U.S. drug maker Gilead Sciences Inc. disclosed today that it will provide Japan with the antiviral drug remdesivir, which the MHLW approved expeditiously as a drug to treat COVID-19, free of charge for the time being. Kyodo said the company had already announced that it would provide the drug free of charge for clinical trials involving 140,000 patients around the world, including Japan. Kyodo noted, however, that the company did not disclose how much of the medicine will be supplied to Japan. 

  • Ambassador
  • Ukraine
  • COVID-19
  • Trending Japan